Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR001200)
Formula
CYP2C9 ...
SVG example
O-Demethylation
Reactant Indomethacin Product 5-hydroxyindomethacin
Reactant Info Product Info
Metabolic Enzyme Cytochrome P450 2C9 (CYP2C9) DME Info
DME Info
Metabolic Type Oxidation - O-Demethylation
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001201 Indomethacin Deacyl indomethacin Unclear Indomethacin [1]
MR001202 Indomethacin Indomethacin acyl glucuronide Conjugation - O-Glucuronidation Indomethacin [2], [3]
MR000043 Indomethacin Indometacin glycine Unclear Acemetacin [4]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001196 5-hydroxyindomethacin 5-hydroxyindomethacin glucuronide Conjugation - Glucuronidation Indomethacin [1]
MR001197 5-hydroxyindomethacin 5-hydroxyindomethacin sulfate Conjugation - Sulfation Indomethacin [1]
References
1 Comparative in vitro metabolism of phospho-tyrosol-indomethacin by mice, rats and humans Biochem Pharmacol. 2013 Apr 15;85(8):1195-202. doi: 10.1016/j.bcp.2013.01.031.
2 Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver. Eur J Clin Pharmacol. 2007 Mar;63(3):289-96.
3 Herb-drug interaction in the protective effect of Alpinia officinarum against gastric injury induced by indomethacin based on pharmacokinetic, tissue distribution and excretion studies in rats. J Pharm Anal. 2021 Apr;11(2):200-209. doi: 10.1016/j.jpha.2020.05.009.
4 [Comparative metabolic studies on [14C]-labelled acemetacin and indometacin in rats (author's transl)] Arzneimittelforschung. 1980;30(8A):1384-91.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.